Identifying Factors Underlying the Discontinuation of Triptans

Mayo Clinic292 enrolled

Overview

The objective of this study is to identify reasons migraine patients stop using triptan medications for abortive headache treatment. It is hypothesized that inadequate education of the patient at the time of prescribing the triptan is positively associated with triptan discontinuation.

Study Type

OBSERVATIONAL

Enrollment

292

Conditions

Migraine Medication Adherence

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Triptan User Inclusion Criteria: * Episodic Migraine or Chronic Migraine * Have used a triptan medication in the prior 3 months * Have used triptan medications for at least 1 year Triptan Discontinuation Inclusion Criteria: * Episodic Migraine or Chronic Migraine * Used any triptan medication in the last 2 years * Have not used a triptan medication in the last 6 months

Locations (3)

University of South Florida College of Medicine

Tampa, Florida, United States

Washington University School of Medicine

St Louis, Missouri, United States

Cleveland Clinic Foundation

Cleveland, Ohio, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.